{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(2)"],"submitter":["Nigrovic LE"],"pubmed_abstract":["<h4>Introduction</h4>Lyme disease is the most common vectorborne disease in the Northern hemisphere with more than 400 000 new cases in the USA annually. Lyme meningitis is an uncommon but potentially serious clinical manifestation of Lyme disease. Intravenous ceftriaxone had been the first-line treatment for Lyme meningitis, but is associated with a high rate of complications. Although efficacy and effectiveness (or real-world evidence) data for oral doxycycline are limited, practice guidelines were recently expanded to recommend either oral doxycycline or ceftriaxone as first-line treatments for Lyme meningitis. Our goal is to compare oral doxycycline with intravenous ceftriaxone for the treatment of Lyme meningitis on short-term recovery and long-term quality of life.<h4>Methods and ana"],"journal":["BMJ open"],"pagination":["e071141"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9980370"],"repository":["biostudies-literature"],"pubmed_title":["Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis in children: a multicentre prospective cohort study."],"pmcid":["PMC9980370"],"pubmed_authors":["Caffrey AR","Race JA","Halperin JJ","Nigrovic LE","Fuller BJ","Lyme Net P","Vargas SE","Morrison BL","Chun TH","Ott U","VanBuren JM"],"additional_accession":[]},"is_claimable":false,"name":"Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis in children: a multicentre prospective cohort study.","description":"<h4>Introduction</h4>Lyme disease is the most common vectorborne disease in the Northern hemisphere with more than 400 000 new cases in the USA annually. Lyme meningitis is an uncommon but potentially serious clinical manifestation of Lyme disease. Intravenous ceftriaxone had been the first-line treatment for Lyme meningitis, but is associated with a high rate of complications. Although efficacy and effectiveness (or real-world evidence) data for oral doxycycline are limited, practice guidelines were recently expanded to recommend either oral doxycycline or ceftriaxone as first-line treatments for Lyme meningitis. Our goal is to compare oral doxycycline with intravenous ceftriaxone for the treatment of Lyme meningitis on short-term recovery and long-term quality of life.<h4>Methods and ana","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-22T21:44:27.677Z","creation":"2025-04-22T21:44:27.677Z"},"accession":"S-EPMC9980370","cross_references":{"pubmed":["36854594"],"doi":["10.1136/bmjopen-2022-071141"]}}